جلد 0 -                   | برگشت به فهرست نسخه ها

XML English Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Amira Q H, Irdianto S A, Fadilah, Lestari R, Fadhillah, Bowolaksono A et al . Caffeine Modulates Cell Death and Telomerase Activity in Triple-negative Breast Cancer Cells. Int J Mol Cell Med 2025;
URL: http://ijmcmed.org/article-1-2555-fa.html
Caffeine Modulates Cell Death and Telomerase Activity in Triple-negative Breast Cancer Cells. مجله بین المللی سلولی و مولکولی. 1404;

URL: http://ijmcmed.org/article-1-2555-fa.html


:   (73 مشاهده)
Triple-negative breast cancer (TNBC) is an aggressive subtype defined by the lack of estrogen receptors (ER), progesterone receptors (PR), and HER2 expression, resulting in limited therapeutic options. Given this challenge, this study explores caffeine, a widely consumed stimulant, as a potential anticancer agent, particularly for TNBC. While caffeine has demonstrated promising anticancer effects in gastric cancer, its effects on TNBC cells remain unexplored. This study investigates the impact of caffeine concentrations (10, 15, and 20 mM) on cell viability, proliferation, apoptosis, ultrastructure, and the expression of apoptosis-related genes (BAX, BCL2, CASP8) and telomerase activity (hTERT) in MDA-MB-231 cells. Our findings showed that caffeine significantly reduces cell viability and induces early apoptosis with a dose-dependent effect. Morphological changes consistent with early apoptosis were observed, and an increased BAX/BCL2 ratio indicated the activation of the intrinsic apoptosis pathway. Additionally, caffeine exhibited upregulation of hTERT mRNA expression, suggesting complex interactions with telomerase activity. These results underscore the multifaceted effects of caffeine on TNBC cells, highlighting its potential not only as an apoptosis inducer but also as a modulator of telomerase activity. Given its accessibility, low toxicity, and established safety profile, caffeine presents an exciting avenue for further research as a complementary or standalone therapeutic strategy for TNBC.
متن کامل [PDF 1260 kb]   (31 دریافت)    
نوع مطالعه: Original Article | موضوع مقاله: Cancer
دریافت: 1403/12/1 | پذیرش: 1404/2/20 | انتشار: 1404/1/23

ارسال نظر درباره این مقاله : نام کاربری یا پست الکترونیک شما:
CAPTCHA

بازنشر اطلاعات
Creative Commons License این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است.

کلیه حقوق این وب سایت متعلق به International Journal of Molecular and Cellular Medicine IJMCM می باشد.

طراحی و برنامه نویسی : یکتاوب افزار شرق

© 2025 CC BY-NC 4.0 | International Journal of Molecular and Cellular Medicine IJMCM

Designed & Developed by : Yektaweb